Publicacions en què col·labora amb José Angel Richter (20)

2020

  1. Incidental diagnosis of neuroendocrine tumour with 68Ga-PSMA PET/CT: Report of clinical case

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 2, pp. 102-103

2018

  1. Significant dose reduction is feasible in FDG PET/CT protocols without compromising diagnostic quality

    Physica Medica, Vol. 46, pp. 134-139

2017

  1. Effective dose estimation for oncological and neurological PET/CT procedures

    EJNMMI Research, Vol. 7, Núm. 1

2016

  1. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT

    Lung Cancer, Vol. 97, pp. 81-86

  2. Factors related to increased resting energy expenditure in men with liver cirrhosis

    European Journal of Gastroenterology and Hepatology, Vol. 28, Núm. 2, pp. 139-145

  3. Index lesion characterization by 11C-Choline PET/CT and Apparent Diffusion Coefficient parameters at 3 Tesla MRI in primary prostate carcinoma

    Prostate, Vol. 76, Núm. 1, pp. 3-12

2015

  1. Brain PET imaging optimization with time of flight and point spread function modelling

    Physica Medica, Vol. 31, Núm. 8, pp. 948-955

2014

  1. PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization

    Medical Physics, Vol. 41, Núm. 9

2013

  1. Aportación del tiempo de vuelo y de la modelización de la respuesta a una fuente puntual a las características de funcionamiento del tomógrafo PET/TAC Biograph mCT

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 32, Núm. 1, pp. 13-21

2012

  1. La tomografía por emisión de positrones

    Medicina nuclear en la práctica clínica (Aula Médica Ediciones), pp. 295-308

  2. PET tracers for clinical imaging of breast cancer

    Journal of Oncology

2011

  1. Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients

    Journal of Immunology, Vol. 187, Núm. 11, pp. 6130-6142

2008

  1. New horizons in breast surgery. Radioguided surgery and selective sentinel node biopsy

    Revista de medicina de la Universidad de Navarra, Vol. 52, Núm. 1, pp. 13-17

  2. Positron emission tomography in breast cancer

    Revista de medicina de la Universidad de Navarra, Vol. 52, Núm. 1, pp. 4-12

  3. Tomografía por emisión de positrones en el cáncer de mama

    Revista de medicina, Vol. 52, Núm. 1, pp. 4-12

  4. Whole body 18fluoro-l-dopa PET-CT: A useful tool for location and surgical guidance in primary carcinoid tumours

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Núm. 8, pp. 1577

2007

  1. La 18FDG-PET: Una nueva aproximación diagnóstica en la infección protésica de cadera

    Revista Espanola de Medicina Nuclear, Vol. 26, Núm. 4, pp. 208-220

2005

  1. Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8

    International Journal of Cancer, Vol. 116, Núm. 2, pp. 275-281

  2. Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients

    Gastroenterology, Vol. 128, Núm. 7, pp. 1787-1795

2004

  1. Positron emission tomography and gene therapy: Basic concepts and experimental approaches for in vivo gene expression imaging

    Molecular Imaging and Biology, Vol. 6, Núm. 4, pp. 225-238